Skip to main content
. 2013 Dec 12;2:e01020. doi: 10.7554/eLife.01020

Figure 1. An ENU mouse mutant with increased CD44hi CD4 cells and anti-nuclear autoantibodies.

(A and B) Representative flow cytometry showing on peripheral blood CD4+ cells (A) CD44 expression with the gate used to define CD44hi cells and (B) FOXP3 vs CD44 phenotype including normalized CD44 Mean Fluorescence Intensity (MFI) of the gated CD44lo FOXP3 subset from Rasgrp1+/+ (WT), heterozygous Rasgrp1Anaef/+ or homozygous Rasgrp1Anaef/Anaef mice. Statistical analysis (right) used unpaired Student’s t tests where each symbol represents an individual mouse; ***p<0.001. (C) Antinuclear antibodies (ANA) in diluted blood plasma from a B6xB10. Rasgrp1Anaef mouse and wildtype littermate, measured by indirect immunofluorescence on HEp-2 cells. Note homogeneous nuclear staining of interphase cells and positive chromatin bars in dividing cells (marked with arrow). Magnification 20 ×. (D) Quantitation of positive ANA results for wildtype, Rasgrp1Anaef/+ and Rasgrp1Anaef/Anaef C57Bl/6xC57Bl/10 siblings tested at 15 weeks of age.

DOI: http://dx.doi.org/10.7554/eLife.01020.003

Figure 1.

Figure 1—figure supplement 1. Mapping and genotyping of the Rasgrp1 mutation in ENU mutant mice with anti-nuclear antibodies and CD44hi phenotype.

Figure 1—figure supplement 1.

(A) SNP analysis of a cohort of F2 mice generated by outcrossing a B6 animal identified as ‘affected’ with CBA, then incrossing F1 offspring to produce the (ENU.B6 × CBA/J) F2 animals listed. Phenotypes of affected mice tracked with a genomic region between 114–121.2 on chromosome 2. The Rasgrp1 gene lies in this interval. (B) Genotyping of Rasgrp1Anaef/Anaef, Rasgrp1Anaef/WT, and wildtype mice in the Roose lab was performed using MS-PCR as described (Rust et al., 1993; Bottema and Sommer, 1993). Products are wt: 202 bp and R519G: 223 bp. (C) Genotyping of Rasgrp1Anaef/Anaef, Rasgrp1Anaef/WT, and wildtype mice using Amplifluor PCR in the Goodnow Lab. The Rasgrp1Anaef strain was established through ethylnitrosourea (ENU)-mediated mutagenesis of B6 mice at the Australian National University as previously described (Randall et al., 2009).